234 related articles for article (PubMed ID: 28403887)
21. Regional activation of the cancer genome by long-range epigenetic remodeling.
Bert SA; Robinson MD; Strbenac D; Statham AL; Song JZ; Hulf T; Sutherland RL; Coolen MW; Stirzaker C; Clark SJ
Cancer Cell; 2013 Jan; 23(1):9-22. PubMed ID: 23245995
[TBL] [Abstract][Full Text] [Related]
22. Re-patterning of H3K27me3, H3K4me3 and DNA methylation during fibroblast conversion into induced cardiomyocytes.
Liu Z; Chen O; Zheng M; Wang L; Zhou Y; Yin C; Liu J; Qian L
Stem Cell Res; 2016 Mar; 16(2):507-18. PubMed ID: 26957038
[TBL] [Abstract][Full Text] [Related]
23. Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth.
Cha TL; Chuang MJ; Tang SH; Wu ST; Sun KH; Chen TT; Sun GH; Chang SY; Yu CP; Ho JY; Liu SY; Huang SM; Yu DS
Mol Carcinog; 2015 Mar; 54(3):167-77. PubMed ID: 24115089
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide bovine H3K27me3 modifications and the regulatory effects on genes expressions in peripheral blood lymphocytes.
He Y; Yu Y; Zhang Y; Song J; Mitra A; Zhang Y; Wang Y; Sun D; Zhang S
PLoS One; 2012; 7(6):e39094. PubMed ID: 22761725
[TBL] [Abstract][Full Text] [Related]
25. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide DNA methylation modified by soy phytoestrogens: role for epigenetic therapeutics in prostate cancer?
Karsli-Ceppioglu S; Ngollo M; Adjakly M; Dagdemir A; Judes G; Lebert A; Boiteux JP; Penault-LLorca F; Bignon YJ; Guy L; Bernard-Gallon D
OMICS; 2015 Apr; 19(4):209-19. PubMed ID: 25831061
[TBL] [Abstract][Full Text] [Related]
27. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
28. Direct ChIP-bisulfite sequencing reveals a role of H3K27me3 mediating aberrant hypermethylation of promoter CpG islands in cancer cells.
Gao F; Ji G; Gao Z; Han X; Ye M; Yuan Z; Luo H; Huang X; Natarajan K; Wang J; Yang H; Zhang X
Genomics; 2014; 103(2-3):204-10. PubMed ID: 24407023
[TBL] [Abstract][Full Text] [Related]
29. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
Kondo Y; Shen L; Cheng AS; Ahmed S; Boumber Y; Charo C; Yamochi T; Urano T; Furukawa K; Kwabi-Addo B; Gold DL; Sekido Y; Huang TH; Issa JP
Nat Genet; 2008 Jun; 40(6):741-50. PubMed ID: 18488029
[TBL] [Abstract][Full Text] [Related]
30. OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.
Bunt J; Hasselt NA; Zwijnenburg DA; Koster J; Versteeg R; Kool M
Acta Neuropathol; 2013 Mar; 125(3):385-94. PubMed ID: 23179372
[TBL] [Abstract][Full Text] [Related]
31. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
32. A novel subtype classification and risk of breast cancer by histone modification profiling.
Chen X; Hu H; He L; Yu X; Liu X; Zhong R; Shu M
Breast Cancer Res Treat; 2016 Jun; 157(2):267-279. PubMed ID: 27178334
[TBL] [Abstract][Full Text] [Related]
33. Tiling histone H3 lysine 4 and 27 methylation in zebrafish using high-density microarrays.
Lindeman LC; Reiner AH; Mathavan S; Aleström P; Collas P
PLoS One; 2010 Dec; 5(12):e15651. PubMed ID: 21187971
[TBL] [Abstract][Full Text] [Related]
34. Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells.
McGarvey KM; Van Neste L; Cope L; Ohm JE; Herman JG; Van Criekinge W; Schuebel KE; Baylin SB
Cancer Res; 2008 Jul; 68(14):5753-9. PubMed ID: 18632628
[TBL] [Abstract][Full Text] [Related]
35. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.
Maruyama R; Toyooka S; Toyooka KO; Virmani AK; Zöchbauer-Müller S; Farinas AJ; Minna JD; McConnell J; Frenkel EP; Gazdar AF
Clin Cancer Res; 2002 Feb; 8(2):514-9. PubMed ID: 11839671
[TBL] [Abstract][Full Text] [Related]
36. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R
Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908
[TBL] [Abstract][Full Text] [Related]
37. DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells.
Nordström L; Andersson E; Kuci V; Gustavsson E; Holm K; Ringnér M; Guldberg P; Ek S
BMC Cancer; 2015 Apr; 15():273. PubMed ID: 25880212
[TBL] [Abstract][Full Text] [Related]
38. The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer.
Karsli-Ceppioglu S; Dagdemir A; Judes G; Lebert A; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
Sci Rep; 2017 Jul; 7(1):6597. PubMed ID: 28747748
[TBL] [Abstract][Full Text] [Related]
39. S-adenosylmethionine treatment affects histone methylation in prostate cancer cells.
Mathes A; Duman MB; Neumann A; Dobreva G; Schmidt T
Gene; 2024 Jan; 893():147915. PubMed ID: 37866662
[TBL] [Abstract][Full Text] [Related]
40. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
Kang GH; Lee S; Lee HJ; Hwang KS
J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
